Pfizer believes in the metaverse: will healthcare thaw the technology’s winter?
The metaverse has faded from buzzword to buzzkill, and the hype that once gripped industries has been quietly brushed under…
All articles by Eve Thomas
Eve Thomas
Eve Thomas is a reporter writing across a variety of sectors with a specific focus on thematic intelligence. She has a BA in English Literature from the University of Sheffield and an MSt in English from Oxford University.
-
-
JP Morgan 2025: Incyte expects period of ‘defining catalysts’
Incyte CEO Hervé Hoppenot has promised investors that 2025 will be “a year that will be full of many defining…
-
FDA CDER director Patrizia Cavazzoni announces resignation
The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research…
-
Alzheimer’s total prevalent cases to reach 22.51 million in 8MM in 2033
Estimates by data analytics company GlobalData suggest that the total prevalent cases of Alzheimer’s disease (according to the DSM-IV criteria)…
-
Eli Lilly’s UK life sciences investment ‘a pivotal moment’, says analyst
Eli Lilly’s recently-announced investment into the UK’s life sciences sector “marks a pivotal moment for the industry”, according to GlobalData’s…
-
Pharma’s data and analytics market forecast to reach to $2.1bn by 2028
Data content management will drive the growing global data and analytics market in the pharmaceutical sector, which will reach a…
-
Novo Nordisk invests $1.2bn in new Denmark facility
Denmark-based pharma giant Novo Nordisk has announced plans to invest DKr8.5bn ($1.2bn) to establish a new production facility in Odense,…
-
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
In an open letter, 77 Nobel laureates have “strongly” urged members of the US Senate to reject Donald Trump’s nomination…
-
Vifor Pharma offers £23m to NHS to resolve CMA investigation
The UK’s Competition and Markets Authority (CMA) has received a £23m ($29m) offer from Vifor Pharma for the NHS to…
-
FDA shares new draft guidance for accelerated approval
The US Food and Drug Administration (FDA) has published new draft guidance for its Accelerated Approval Program, which provides a…